AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc.
Thomas Jefferson University
Cyteir Therapeutics, Inc.
Celgene
Weill Medical College of Cornell University
National Cancer Institute (NCI)
Kantonsspital Aarau
Jichi Medical University
Southern Europe New Drug Organization
Charite University, Berlin, Germany